to equity holders of the-42 55449 564CompanyCONSOLIDATED STATEMENT OF FINANCIAL POSITION PLN`000AssetsNotesAs at the

to equity holders of the-42 55449 564CompanyCONSOLIDATED STATEMENT OF FINANCIAL POSITION PLN`000AssetsNotesAs at the end As at the end of period: 31 As at the end of period: 31 of period: 31 Dec. If Rolen does go down Marco Scutaro will be the next in line for the position.Scott Rolen: Rolen, 32, has spent the last 5 seasons in St. Louis with the Cardinals after spending the previous 6 with the Phillies. The six time gold-glover appeared in 112 games last year batting .265 and adding eight home runs and 58 RBIs. Rolen is arguably the best defender at third in the majors when he's healthy and could really help out the Jays situation on D.There you have it, the Jays infield for 2008. Lots of new faces, but should be a good year for the Jays if these guys can stay healthy.In the third and final part of my preview of the '08 season for the Jays, I'll fill you in on the outfield and DH situation.. NEW YORK, April 29 /PRNewswire-FirstCall/ — IAC (Nasdaq: IACI) todayannounced the acquisition of Urbanspoon, a leading online local restaurantguide that aggregates restaurant reviews from across the web, from newspapersand professional food critics to bloggers and diners.

Urbanspoon will remainan independent brand and a wholly-owned business of IAC, and will report toJay Herratti who oversees Citysearch, InsiderPages and Evite. Terms of thedeal have not been disclosed.For IAC, Urbanspoon rounds out a portfolio of premium local brands whichinclude Citysearch, ServiceMagic, InsiderPages, and strategic investments inOpenTable and MerchantCircle. With a wealth of trusted restaurant content, anavid user community, and a leading iPhone application, the acquisition ofUrbanspoon will further solidify IAC’s leadership role in the local space.Integrating Urbanspoon’s content across IAC’s local sites, includingCitysearch and InsiderPages, further reiterates IAC’s commitment to building arobust infrastructure of local content for consumers all across the web.”With a dedicated and comprehensive focus on restaurants, Urbanspoon is apioneer in the online and mobile space with a truly unique, innovative andconsumer-friendly product,” said Jay Herratti, CEO of Citysearch. “With access to IAC’sresources, we can expand our reach and develop new products while maintainingour brand identity.”The deal closed on February 13th, 2009.About UrbanspoonUrbanspoon is a leading online local restaurant guide that aggregatesrestaurant reviews from across the web, from newspapers and professional foodcritics to bloggers and diners. Available online or via its popular iPhoneapplication, Urbanspoon provides reviews for restaurants throughout the UnitedStates, Canada, the United Kingdom and Australia Urbanspoon is an operatingbusiness of IAC (Nasdaq: IACI). For more information, visit IACIAC operates more than 35 leading and diversified Internet businesses across40 countries…

our mission is to harness the power of interactivity to makedaily life easier and more productive for people all over the world. To view afull list of the companies of IAC please visit our website at Investor Relations:IAC Corporate Communications:Eoin RyanStacy Simpson / Leslie Cafferty(212) 314-7432 (212) 314-7470 / 7326Urbanspoon:Brandi Willard310-360-4602SOURCEIACInvestor Relations, Eoin Ryan of IAC, +1-212-314-7432, or CorporateCommunications, Stacy Simpson, +1-212-314-7470, or Leslie Cafferty,+1-212-314-7326, both of IAC; or Brandi Willard of Urbanspoon,+1-310-360-4602. Shengtai Pharmaceutical Hosts Key Customers at Its Headquarters for FacilityTour and Technology Exchange ConferenceWEIFANG, Shandong, China, April 29 /PRNewswire-Asia-FirstCall/ — ShengtaiPharmaceutical, Inc. (OTC Bulletin Board: SGTI) (“Shengtai” or “the Company”),a leading manufacturer and distributor of high-quality, pharmaceutical gradeglucose products in China, today announced that it hosted a conference at theCompany’s headquarters to showcase its newstate-of-the-art 120,000-ton glucose production facility as well as conductedhigh-level discussions with key existing customers.Representatives and officials from over 70 current customers were on handfor the three-day event Mr. Qingtai Liu, Chairman of Shengtai and othersenior members of the Company spoke during the conference as they presentedtheir view on the current operating environment, status of the glucoseproduction facility, as well as high level discussions on strategies that canhelp the Company to continue to deliver on its promise to provide the highestquality products to end customers. The three-day conference also offered theguests with an opportunity to visit the on-site production facilities. Theevent provided the Company management with valuable information on customers’expectations and motivations, and strategic insights into what the Companyneeds to do to further business development and cooperation with its keycustomers.

Many of whom attended the conference congratulated the Company forconsistently delivering high quality products. They also stated they lookforward to continuing to work closely with the Company as it is on its way tobecoming the top domestic supplier of pharmaceutical grade glucose.”The activities of this past week not only gave us an opportunity toshowcase our state-of-the-art production facilities, our customers were ableto gain a better understanding of our operations, production capabilities, andquality control as we develop deeper and more meaningful relationship withmany of our key customers,” said Mr Qingtai Liu, CEO of ShengtaiPharmaceutical, Inc. “In order to compete more effectively in thesechallenging times, we must continue to show improvement in terms of productdevelopment as well as optimize customers overall experience. As one of theleading domestic producers of pharmaceutical grade glucose, we have aresponsibility to produce the highest quality products.Our criticalhealth-related products have achieved global quality standards, and ourstrategic location gives us cost advantage which will benefit our customers byusing our products. As we look ahead, the Company is poised to be one of themajor beneficiaries from the changing healthcare landscape as a result of theplanned government reform.”About Shengtai Pharmaceutical, Inc.Shengtai Pharmaceutical, Inc through its wholly owned subsidiary,Shengtai Holding, Inc.

(SHI), and the Chinese operating company of WeifangShengtai Pharmaceutical Co., Ltd., is a leading manufacturer and supplier ofpharmaceutical grade glucose used for medical purposes.It also manufacturesand supplies glucose and cornstarch products to the food, beverage andindustrial production industries in China.Forward-looking StatementsCertain statements made in this news release, may contain forward-lookingstatements concerning the Company’s business and products. These statementsinclude, without limitation, statements regarding our ability to prepare theCompany for growth, future increases in market demand, possible increases inour market share and predictions and guidance relating to the Company’s futurefinancial performance. Investors are urged to consider these factors carefullyin evaluating the forward-looking statements herein and are cautioned not toplace undue reliance on such forward-looking statements, which are qualifiedin their entirety by this cautionary statement. The forward-looking statementsmade herein speak only as of the date of this press release and the Companyundertakes no duty to update any forward-looking statement to conform thestatement to actual results or changes in the Company’s expectations.For more information, please contact:Shengtai Pharmaceutical, Inc Ms.